{"transactions":[{"id":4638778,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-10-09T21:04:08.000Z","date":"2026-10-07","kind":"sale","planned":false,"acquired":false,"shares":2241,"price":32.06,"value":71846.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 1, 2025, the holder was granted 76,181 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 3, 2025, of which 4,761 of these RSUs vested on October 1, 2026.\nThe sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.58 - $32.30 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":217060,"source":{"system":"sec-edgar","filing":"0001764013-26-000112","document":"wk-form4_1791579845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000176401326000112/wk-form4_1791579845.xml","form_type":"4"}},{"id":678995,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-21T20:03:52.000Z","date":"2026-08-20","kind":"sale","planned":false,"acquired":false,"shares":3056,"price":44.16,"value":134952.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 18, 2024, the holder was granted 109,956 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on November 20, 2024, of which 6,872 of these RSUs vested on August\n18, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is\nmandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.80 - $44.37 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":219301,"source":{"system":"sec-edgar","filing":"0001973838-26-000007","document":"wk-form4_1787342630.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000197383826000007/wk-form4_1787342630.xml","form_type":"4"}},{"id":711259,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-07-10T20:15:18.000Z","date":"2026-07-08","kind":"sale","planned":false,"acquired":false,"shares":106,"price":39.99,"value":4238.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 1, 2025, the holder was granted 76,181 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 3, 2025, of which 4,761 of these RSUs vested on July 1, 2026.\nThe sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.92 - $40.03 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":222357,"source":{"system":"sec-edgar","filing":"0001764013-26-000083","document":"wk-form4_1783714509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000176401326000083/wk-form4_1783714509.xml","form_type":"4"}},{"id":711258,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-07-10T20:15:18.000Z","date":"2026-07-08","kind":"sale","planned":false,"acquired":false,"shares":1930,"price":39.53,"value":76292.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 1, 2025, the holder was granted 76,181 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 3, 2025, of which 4,761 of these RSUs vested on July 1, 2026.\nThe sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.91 - $39.89 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":222463,"source":{"system":"sec-edgar","filing":"0001764013-26-000083","document":"wk-form4_1783714509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000176401326000083/wk-form4_1783714509.xml","form_type":"4"}},{"id":725668,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-26T23:46:51.000Z","date":"2026-06-26","kind":"sale","planned":false,"acquired":false,"shares":2966,"price":38.95,"value":115525.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.78 - $39.13 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":224393,"source":{"system":"sec-edgar","filing":"0001764013-26-000075","document":"wk-form4_1782517606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000176401326000075/wk-form4_1782517606.xml","form_type":"4"}},{"id":725667,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-26T23:46:51.000Z","date":"2026-06-26","kind":"sale","planned":false,"acquired":false,"shares":14748,"price":38.18,"value":563078.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.77 - $38.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":227359,"source":{"system":"sec-edgar","filing":"0001764013-26-000075","document":"wk-form4_1782517606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000176401326000075/wk-form4_1782517606.xml","form_type":"4"}},{"id":766275,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-22T20:03:32.000Z","date":"2026-05-20","kind":"sale","planned":false,"acquired":false,"shares":1698,"price":32.95,"value":55949.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 18, 2024, the holder was granted 109,956 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on November 20, 2024, of which 6,872 of these RSUs vested on\nMay 18, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The\nsale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the\nReporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.55 - $33.49 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":242107,"source":{"system":"sec-edgar","filing":"0001764013-26-000067","document":"wk-form4_1779480209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000176401326000067/wk-form4_1779480209.xml","form_type":"4"}},{"id":766274,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-22T20:03:32.000Z","date":"2026-05-20","kind":"sale","planned":false,"acquired":false,"shares":1168,"price":32.15,"value":37551.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 18, 2024, the holder was granted 109,956 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on November 20, 2024, of which 6,872 of these RSUs vested on\nMay 18, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The\nsale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the\nReporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.55 - $32.50 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":243805,"source":{"system":"sec-edgar","filing":"0001764013-26-000067","document":"wk-form4_1779480209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000176401326000067/wk-form4_1779480209.xml","form_type":"4"}},{"id":766273,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-22T20:03:32.000Z","date":"2026-05-20","kind":"sale","planned":false,"acquired":false,"shares":249,"price":30.41,"value":7572.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 18, 2024, the holder was granted 109,956 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on November 20, 2024, of which 6,872 of these RSUs vested on\nMay 18, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The\nsale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the\nReporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.32 - $31.00 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":244973,"source":{"system":"sec-edgar","filing":"0001764013-26-000067","document":"wk-form4_1779480209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000176401326000067/wk-form4_1779480209.xml","form_type":"4"}},{"id":810576,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-04-10T20:03:58.000Z","date":"2026-04-08","kind":"sale","planned":false,"acquired":false,"shares":8722,"price":24.83,"value":216567.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 1, 2025, the holder was granted 76,181 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 3, 2025, of which 19,045 of these RSUs vested on\nApril 1, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The\nsale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the\nReporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.54 - $25.39 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":245222,"source":{"system":"sec-edgar","filing":"0001973838-26-000004","document":"wk-form4_1775851435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000197383826000004/wk-form4_1775851435.xml","form_type":"4"}},{"id":811649,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-04-09T20:20:39.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":121063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted pursuant to the Plan. The shares underlying the options will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in thirty-six (36) successive substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":121063,"derivative":{"exercise_price":24.61,"expiration_date":"2036-04-07","underlying":"Common Stock","underlying_shares":121063},"source":{"system":"sec-edgar","filing":"0001764013-26-000040","document":"wk-form4_1775766037.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000176401326000040/wk-form4_1775766037.xml","form_type":"4"}},{"id":811648,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-04-09T20:20:39.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":83671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the \"Plan\"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":253944,"source":{"system":"sec-edgar","filing":"0001764013-26-000040","document":"wk-form4_1775766037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000176401326000040/wk-form4_1775766037.xml","form_type":"4"}},{"id":877581,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:07:42.000Z","date":"2026-02-25","kind":"sale","planned":false,"acquired":false,"shares":942,"price":28.9,"value":27223.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 18, 2024, the holder was granted 109,956 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on November 20, 2024, of which 6,872 of these RSUs vested on\nFebruary 18, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs.\nThe sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the\nReporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.70 - $29.13 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":170273,"source":{"system":"sec-edgar","filing":"0001764013-26-000013","document":"wk-form4_1772226458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000176401326000013/wk-form4_1772226458.xml","form_type":"4"}},{"id":877580,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:07:42.000Z","date":"2026-02-25","kind":"sale","planned":false,"acquired":false,"shares":859,"price":28.16,"value":24189.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 18, 2024, the holder was granted 109,956 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on November 20, 2024, of which 6,872 of these RSUs vested on\nFebruary 18, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs.\nThe sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the\nReporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.67 - $28.61 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":171215,"source":{"system":"sec-edgar","filing":"0001764013-26-000013","document":"wk-form4_1772226458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000176401326000013/wk-form4_1772226458.xml","form_type":"4"}},{"id":877579,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:07:42.000Z","date":"2026-02-25","kind":"sale","planned":false,"acquired":false,"shares":1437,"price":26.98,"value":38770.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 18, 2024, the holder was granted 109,956 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on November 20, 2024, of which 6,872 of these RSUs vested on\nFebruary 18, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs.\nThe sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the\nReporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.66 - $27.60 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":172074,"source":{"system":"sec-edgar","filing":"0001764013-26-000013","document":"wk-form4_1772226458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000176401326000013/wk-form4_1772226458.xml","form_type":"4"}},{"id":991516,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-11-21T21:24:08.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":2375,"price":23.97,"value":56928.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 18, 2024, the holder was granted 109,956 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on November 20, 2024, of which 27,489 of these RSUs vested on November 18, 2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.93 - $24.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":173511,"source":{"system":"sec-edgar","filing":"0001764013-25-000156","document":"wk-form4_1763760245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000176401325000156/wk-form4_1763760245.xml","form_type":"4"}},{"id":991515,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-11-21T21:24:08.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":10251,"price":23.54,"value":241308.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 18, 2024, the holder was granted 109,956 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on November 20, 2024, of which 27,489 of these RSUs vested on November 18, 2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.93 - $23.91 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":175886,"source":{"system":"sec-edgar","filing":"0001764013-25-000156","document":"wk-form4_1763760245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000176401325000156/wk-form4_1763760245.xml","form_type":"4"}},{"id":1180186,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-03T20:53:33.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":107297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the options will vest as to 25% of the shares on April 1, 2026 and the remainder will vest in 36 substantially equal monthly installments over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":107297,"derivative":{"exercise_price":15.2,"expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":107297},"source":{"system":"sec-edgar","filing":"0001764013-25-000057","document":"wk-form4_1743713606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000176401325000057/wk-form4_1743713606.xml","form_type":"4"}},{"id":1180185,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-04-03T20:53:33.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":76181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the units on April 1, 2026, and the remainder will vest in substantially equal installments on a quarterly basis over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":186137,"source":{"system":"sec-edgar","filing":"0001764013-25-000057","document":"wk-form4_1743713606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000176401325000057/wk-form4_1743713606.xml","form_type":"4"}},{"id":1357524,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-20T22:15:40.000Z","date":"2024-11-18","kind":"grant","planned":false,"acquired":true,"shares":137446,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted pursuant to the Issuer's 2019 Equity Incentive Plan. The shares underlying the option will vest as to 25% of the shares on November 18, 2025, and the remainder will vest in 12 successive substantially equal quarterly installments over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":137446,"derivative":{"exercise_price":25.51,"expiration_date":"2034-11-18","underlying":"Common Stock","underlying_shares":137446},"source":{"system":"sec-edgar","filing":"0001764013-24-000188","document":"wk-form4_1732140934.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000176401324000188/wk-form4_1732140934.xml","form_type":"4"}},{"id":1357523,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-11-20T22:15:40.000Z","date":"2024-11-18","kind":"grant","planned":false,"acquired":true,"shares":109956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the units on November 18, 2025, and the remainder will vest in 12 successive substantially equal quarterly installments over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":109956,"source":{"system":"sec-edgar","filing":"0001764013-24-000188","document":"wk-form4_1732140934.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000176401324000188/wk-form4_1732140934.xml","form_type":"4"}},{"id":1502262,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-05-24T23:06:11.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":184042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% of the shares subject to the option vest on December 15, 2024, 34% of the shares subject to the option vest on June 15, 2025, and the remaining 33% of the shares subject to the option vest on December 15, 2025, subject to the Reporting Person's continued service."}],"balance_after":184042,"derivative":{"exercise_price":4.22,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":184042},"source":{"system":"sec-edgar","filing":"0001962918-24-000067","document":"wk-form4_1716591959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000196291824000067/wk-form4_1716591959.xml","form_type":"4"}},{"id":1511923,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-05-17T23:12:49.000Z","date":"2024-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":10298,"price":4.47,"value":46032.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the total number of shares withheld to settle the Reporting Person's tax liability for the Restricted Stock Units that vested on May 15, 2024."}],"balance_after":130286,"source":{"system":"sec-edgar","filing":"0001962918-24-000063","document":"wk-form4_1715987559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000196291824000063/wk-form4_1715987559.xml","form_type":"4"}},{"id":1680917,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-11T23:31:02.000Z","date":"2024-01-09","kind":"grant","planned":false,"acquired":true,"shares":494297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to the option vest on January 9, 2025, and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service."}],"balance_after":494297,"derivative":{"exercise_price":7.68,"expiration_date":"2034-01-08","underlying":"Common Stock","underlying_shares":494297},"source":{"system":"sec-edgar","filing":"0001962918-24-000006","document":"wk-form4_1705015852.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000196291824000006/wk-form4_1705015852.xml","form_type":"4"}},{"id":1802135,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-08-18T22:50:36.000Z","date":"2023-08-16","kind":"grant","planned":false,"acquired":true,"shares":140584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (RSUs). 1/4 of the RSUs will vest on May 15, 2024 and the remaining RSUs will vest in three equal annual installments thereafter, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":140584,"source":{"system":"sec-edgar","filing":"0001962918-23-000022","document":"wk-form4_1692399025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000196291823000022/wk-form4_1692399025.xml","form_type":"4"}},{"id":1896982,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-05-12T00:56:25.000Z","date":"2023-05-09","kind":"other","planned":false,"acquired":true,"shares":232436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vest on May 4, 2024, and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."}],"balance_after":232436,"derivative":{"exercise_price":18,"expiration_date":"2033-05-03","underlying":"Common Stock","underlying_shares":232436},"source":{"system":"sec-edgar","filing":"0001209191-23-028868","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000120919123028868/doc4.xml","form_type":"4"}},{"id":1896981,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-05-12T00:56:25.000Z","date":"2023-05-09","kind":"other","planned":false,"acquired":false,"shares":232436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vest on May 4, 2024, and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."}],"balance_after":0,"derivative":{"exercise_price":18,"expiration_date":"2033-05-03","underlying":"Class A Common Stock","underlying_shares":232436},"source":{"system":"sec-edgar","filing":"0001209191-23-028868","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000120919123028868/doc4.xml","form_type":"4"}},{"id":1896980,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-05-12T00:56:25.000Z","date":"2023-05-09","kind":"other","planned":false,"acquired":true,"shares":187988,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the option vest on November 17, 2023, and 1/48 of the shares subject to the option vests in equal monthly installments thereafter, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."}],"balance_after":187988,"derivative":{"exercise_price":5.8766,"expiration_date":"2032-11-20","underlying":"Common Stock","underlying_shares":187988},"source":{"system":"sec-edgar","filing":"0001209191-23-028868","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000120919123028868/doc4.xml","form_type":"4"}},{"id":1896979,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-05-12T00:56:25.000Z","date":"2023-05-09","kind":"other","planned":false,"acquired":false,"shares":187988,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the option vest on November 17, 2023, and 1/48 of the shares subject to the option vests in equal monthly installments thereafter, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."}],"balance_after":0,"derivative":{"exercise_price":5.8766,"expiration_date":"2032-11-20","underlying":"Class A Common Stock","underlying_shares":187988},"source":{"system":"sec-edgar","filing":"0001209191-23-028868","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000120919123028868/doc4.xml","form_type":"4"}},{"id":1896978,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-05-12T00:56:25.000Z","date":"2023-05-09","kind":"other","planned":false,"acquired":true,"shares":330181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the option vested on November 8, 2022 and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."}],"balance_after":330181,"derivative":{"exercise_price":4.0426,"expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":330181},"source":{"system":"sec-edgar","filing":"0001209191-23-028868","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000120919123028868/doc4.xml","form_type":"4"}},{"id":1896977,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-05-12T00:56:25.000Z","date":"2023-05-09","kind":"other","planned":false,"acquired":false,"shares":330181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the option vested on November 8, 2022 and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."}],"balance_after":0,"derivative":{"exercise_price":4.0426,"expiration_date":"2032-01-19","underlying":"Class A Common Stock","underlying_shares":330181},"source":{"system":"sec-edgar","filing":"0001209191-23-028868","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000120919123028868/doc4.xml","form_type":"4"}},{"id":1904656,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":20900,"kind":"person","name":"Gloria Melanie","position":1,"cik":"0001973838","reported_name":"Gloria Melanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-05-05T00:03:56.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":232436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to the option vest on May 4, 2024, and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each share of Class A Common Stock shall be reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."}],"balance_after":232436,"derivative":{"exercise_price":18,"expiration_date":"2033-05-03","underlying":"Class A Common Stock","underlying_shares":232436},"source":{"system":"sec-edgar","filing":"0001209191-23-027518","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1973838/000120919123027518/doc4.xml","form_type":"4"}}]}